Schond Greenway - May 23, 2022 Form 4/A - Amendment Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role
Chief Financial Officer
Signature
/s/ Schond L. Greenway
Stock symbol
MNMD
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/3/2022, 04:06 PM
Date Of Original Report
May 23, 2022
Previous filing
Dec 14, 2021
Next filing
Apr 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNMD Subordinate Voting Shares Award $0 +1.27M $0.00 1.27M May 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNMD Stock Option (Right to Buy) Award $0 +1.65M $0.00 1.65M May 23, 2022 Subordinate Voting Shares 1.65M $0.78 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one subordinate voting share of the Issuer. Of these RSUs, 25% shall vest on May 23, 2023 with 1/12th of the remaining shares vesting each quarter thereafter over 12 quarters, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.
F2 The option grant has an exercise price of $1.00 Canadian Dollars. This represents the exercise price in United States Dollars.
F3 The shares subject to the option vest and become exercisable, with 25% vesting on May 23, 2023, and 1/36th of the remaining shares vesting monthly thereafter over 36 months, subject to the Reporting Person providing continuous service to the Issuer as of each such vesting date.

Remarks:

Explanatory Note: This Amendment on Form 4/A is being filed to amend the Form 4 filed on May 23, 2022 solely to update the Exercise Price of the Stock Option in Table 2 and Explanation of Responses 2.